INCA: The Involvement of Breast Cancer Patients During Oncological Consultations

Sponsor
Azienda Ospedaliera Universitaria Integrata Verona (Other)
Overall Status
Completed
CT.gov ID
NCT01510964
Collaborator
(none)
300
1
2
23
13

Study Details

Study Description

Brief Summary

The main aim of the study is to assess if a pre consultation intervention facilitates greater participation of patients (and accompanying key persons when present) in the consultation process by determining an increase in questioning and/or in the number of different illness related issues (e.g. diagnosis, treatment, prognosis) being discussed with the oncologist.

Other aims are to assess the effect of the intervention on the oncologist's level of patient involvement, on patient satisfaction and coping and to explore the role of key persons accompanying the patient.

The investigators expect that patients who have the opportunity to rehearse their informative needs before the consultation will ask a greater number of questions which in turn will determine their greater involvement by the physician and a greater number of satisfied needs. The investigators expect also that the straightforward use of a list of printed questions of potential relevance for cancer patients and their companions at an early stage of illness, by modifying the process of information exchange, increases their participation and satisfaction with the consultation, with potential benefits for treatment adherence and consequently treatment efficacy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: prompt-sheet
  • Behavioral: control group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Involvement of Breast Cancer Patients During Oncological Consultations. A Multi-centre Randomized Controlled Trial. The Study Protocol
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
May 1, 2013
Actual Study Completion Date :
May 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: prompt-sheet

Patients and companions of intervention group receive a form on which to write their reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist" and the prompt sheet. An introduction explains the importance of asking questions during the consultations. The patient (companion) is invited to select among a written list of about 50 possible questions those, if any, s/he would like to ask today to the oncology.

Behavioral: prompt-sheet
Prompt sheet is a form on which to write the reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist" and a written list of possible questions the patient (companion) would like to ask to the oncology.

Other: control group

Patients and companions of the control group receive a form on which to write their reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist"

Behavioral: control group
Patients and companions of the control group receive a form on which to write their reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist"

Outcome Measures

Primary Outcome Measures

  1. number of question during the consultation [1 hour after the intervention (question prompt-sheet)]

    The intervention prompt-sheet aims to increase the number of question by giving the opportunity to patients and companions to reflect on their informative needs on the basis of a wide range of possible questions from which to choose those perceived as most relevant in view of the subsequent consultation. Question asking is considered an index for patient participation during the consultation. The total number of patient questions during the consultation regarding diagnosis, prognosis, treatment and other issues is the primary outcome measure.

Secondary Outcome Measures

  1. The number of informative needs not met during the consultation. [1 hour after the intervention (question prompt-sheet)]

    This measure is derived by comparing the number of questions indicated by patients and their companion before the consultation with those actually raised during the consultation

  2. Ability to cope with the illness [2 hours after the intervention (question prompt-sheet)]

    the Patient Enablement Instrument (PEI) is a questionnaire of six items on a Likert scale from 0 (same or less) to 2 (much better, much more), administered after the consultation.

  3. Patient involvement (SDM-Q and OPTION) [2 hours after the intervention (question prompt-sheet)]

    The SDM-Q is a self administered questionnaire of 9 items on a Likert scale from 1 to 6 and assesses patients' perception of the decisional process and their level of involvement during the consultation. The OPTION Scale is composed of 12 items of operational definitions of different patient involving skills, rated on a Likert scale from 0 to 4. The scale is applied by trained raters to the audio-recording of the consultation

  4. Satisfaction with decisions (SWD). [2 hours after the intervention (question prompt-sheet)]

    Satisfaction with Decision Scale (SWD) is a questionnaireof 6 items on a Likert scale from 0 (completely disagree) to 5 (agree completely), administered after the consultation.

  5. Recalling and understanding of information [2 hours after the intervention (question prompt-sheet)]

    The Recall Questionnaire consists of six questions which ask the patient's to recall the received information on treatment decisions and pathology. We added three other questions, rated on a 0 (no at al) to 5 (very much) likert scale asking whether the patient succeeded in their purpose of question asking, whether the oncologist answered the questions properly and how much more information she would have needed.

  6. Overall consultation atmosphere (VR-COPE, RIAS, AIMIT on the audio-recorded consultation) [1 hour after the intervention (question prompt-sheet)]

    VRCOPE assesses the content, the process and relational aspects of patient-centred communication during medical consultations on the basis of a multidimensional evaluation and comprises nine items. RIAS is a coding system of medical consultations, composed by 40 categories describing interactions between doctors and patients. AIMIT is a coding system to assess in the therapeutic dialogue the activity of interpersonal motivational systems that guide the verbal and non verbal behaviors during interactions.

  7. Perceived Patient-doctor relationship (PDRQ-9 and DDPRQ-10) [2 hours after the intervention (question prompt-sheet)]

    PDRQ-9 is a self-administered (after the consultation) questionnaire of 9 items on a Likert scale from 1 to 5, to measure the relationship between the doctor and the patient, from a patient point of view.The DDPRQ-10 is a self-report instrument of 10 items on a Likert scale from 1 to 6, completed by physicians after an encounter with a patient.

  8. Perceived role preference of the patient (CPS) [2 hours after the intervention (question prompt-sheet)]

    CPS (Oncologist version) assesses how the oncologist perceives the role that patient might prefer regarding the decision making process.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all consecutive patients

  • age between 18 and 75 years

  • attending the Oncology Out-patient Clinics of the participating centres

  • recent diagnosis of breast cancer at an early stage

Exclusion Criteria:
  • presence of metastasis or relapse

  • severe mental deterioration

  • comprehension difficulties of the Italian language.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Ospedaliera Universitaria Integrata Verona Italy 37134

Sponsors and Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

Investigators

  • Principal Investigator: Claudia Goss, Universita di Verona

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Azienda Ospedaliera Universitaria Integrata Verona
ClinicalTrials.gov Identifier:
NCT01510964
Other Study ID Numbers:
  • INCA (CE.Prot. 1719)
First Posted:
Jan 18, 2012
Last Update Posted:
Aug 13, 2013
Last Verified:
Dec 1, 2011
Keywords provided by Azienda Ospedaliera Universitaria Integrata Verona
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 13, 2013